CN1348451A - 治疗抑郁症的氮杂吲哚衍生物 - Google Patents

治疗抑郁症的氮杂吲哚衍生物 Download PDF

Info

Publication number
CN1348451A
CN1348451A CN00806589A CN00806589A CN1348451A CN 1348451 A CN1348451 A CN 1348451A CN 00806589 A CN00806589 A CN 00806589A CN 00806589 A CN00806589 A CN 00806589A CN 1348451 A CN1348451 A CN 1348451A
Authority
CN
China
Prior art keywords
compound
following formula
ring
halogen
heterocycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00806589A
Other languages
English (en)
Chinese (zh)
Inventor
R·E·穆肖
K·L·梅赫尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of CN1348451A publication Critical patent/CN1348451A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN00806589A 1999-04-22 2000-04-20 治疗抑郁症的氮杂吲哚衍生物 Pending CN1348451A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29673699A 1999-04-22 1999-04-22
US09/296,736 1999-04-22

Publications (1)

Publication Number Publication Date
CN1348451A true CN1348451A (zh) 2002-05-08

Family

ID=23143341

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00806589A Pending CN1348451A (zh) 1999-04-22 2000-04-20 治疗抑郁症的氮杂吲哚衍生物

Country Status (8)

Country Link
EP (1) EP1171439A1 (es)
JP (1) JP2002543079A (es)
CN (1) CN1348451A (es)
AR (1) AR028475A1 (es)
AU (1) AU4364400A (es)
BR (1) BR0010693A (es)
CA (1) CA2367681A1 (es)
WO (1) WO2000064898A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100338062C (zh) * 2002-03-28 2007-09-19 卫材株式会社 作为c－Jun N－末端激酶抑制剂的氮杂吲哚类化合物

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7635696B2 (en) 2004-11-26 2009-12-22 Janssen Pharmaceutica N.V. Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic activity
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
US20100190777A1 (en) 2007-07-17 2010-07-29 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
WO2010114928A2 (en) 2009-04-03 2010-10-07 F.Hoffmann-La Roche Ag Compositions and uses thereof
JP5721706B2 (ja) 2009-06-17 2015-05-20 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ インフルエンザウイルス複製の阻害剤
ES2633317T3 (es) 2009-11-06 2017-09-20 Plexxikon, Inc. Compuestos y métodos para la modulación de quinasas, e indicaciones para ello
CN103492381A (zh) 2010-12-16 2014-01-01 沃泰克斯药物股份有限公司 流感病毒复制的抑制剂
AU2012214762B2 (en) 2011-02-07 2015-08-13 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
AR085279A1 (es) 2011-02-21 2013-09-18 Plexxikon Inc Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
SI3421468T1 (sl) 2013-11-13 2021-03-31 Vertex Pharmaceuticals Incorporated Postopki za pripravo inhibitorjev replikacije virusov influence
CN105849100B (zh) 2013-11-13 2019-07-16 沃泰克斯药物股份有限公司 流感病毒复制抑制剂
EP3294717B1 (en) 2015-05-13 2020-07-29 Vertex Pharmaceuticals Inc. Methods of preparing inhibitors of influenza viruses replication
JP6857617B2 (ja) 2015-05-13 2021-04-14 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ インフルエンザウイルスの複製の阻害剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521197A (en) * 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
US5627196A (en) * 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100338062C (zh) * 2002-03-28 2007-09-19 卫材株式会社 作为c－Jun N－末端激酶抑制剂的氮杂吲哚类化合物

Also Published As

Publication number Publication date
AR028475A1 (es) 2003-05-14
BR0010693A (pt) 2002-02-05
WO2000064898A1 (en) 2000-11-02
CA2367681A1 (en) 2000-11-02
AU4364400A (en) 2000-11-10
JP2002543079A (ja) 2002-12-17
EP1171439A1 (en) 2002-01-16

Similar Documents

Publication Publication Date Title
CN1348451A (zh) 治疗抑郁症的氮杂吲哚衍生物
CN105814067B (zh) 作为钠通道调节剂的吡啶酮酰胺的前药
CN105026373B (zh) 作为钠通道调节剂的吡啶酮酰胺
CN104968647B (zh) 作为钠通道调节剂的酰胺
CN103649056B (zh) 作为离子通道调节剂的稠合杂环化合物
CN103857288B (zh) 作为激酶抑制剂的氨基-喹啉
CN103153963B (zh) 环丙烷化合物
CN106103416A (zh) 作为trpm8拮抗剂的氮杂螺衍生物
CN101300259A (zh) 作为crth2调节剂的三环螺衍生物
CN101018770A (zh) 炎性疾病治疗用pgd2受体拮抗剂
WO2007010383A1 (ja) 新規なヘテロシクリデンアセトアミド誘導体
CN101035526A (zh) 用于治疗高眼压的眼用组合物
CN101948425A (zh) 作为糖皮质激素配体的化合物、包含它们的药物组合物、试剂盒及其制备方法
CN101511805A (zh) 作为多巴胺d3受体配体的新型羰基化(氮杂)环己烷类化合物
CN1209805A (zh) 新型稠合的吡咯碳酰胺、新一类的gaba脑受体配位体
CN104936958B (zh) 作为γ分泌酶调节剂的新颖的经取代的吡啶并-哌嗪酮衍生物
WO1999043660A1 (en) Substituted 1,4-dihydro-4-oxonicotinic carboxamides: gaba brain receptor ligands
CN101917987A (zh) 治疗精神病障碍的aldh-2抑制剂
WO2014180165A1 (zh) 苯并异噻唑类化合物及在制备抗精神***症药物中的应用
CN105143188A (zh) 新型磺酰胺trpa1受体拮抗剂
JP2004535413A (ja) Ｋｃｎｑカリウムチャンネルモジュレーターとしてのシンナミド誘導体
CN1059441C (zh) 苯并吡喃醇类化合物、其制法及其药物组合物与用途
CN102781914B (zh) 吲哚衍生物
CN1988903A (zh) 用于治疗高眼压症的眼用组合物
KR20060080197A (ko) 카르복실산 화합물 및 이들을 유효 성분으로서 함유하는의약 조성물

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication